Thursday, October 22, 2020
Home Latest Pharma-News

Latest Pharma-News

Roche signs deal with Dyno Therapeutics for gene therapy vectors

October 14, 2020: "Dyno Therapeutics, a biotech company applying artificial intelligence (AI) to gene therapy, announced a collaboration and license agreement with...

NIHR publishes dynamic themed review into ‘ongoing COVID’

October 15, 2020: "The National Institute for Health Research Centre for Engagement and Dissemination has today published its first dynamic themed review of the...

RPS calls for action to fight counterfeit medicines

October 13, 2020: The Royal Pharmaceutical Society of Great Britain (RPS) has called on the UK government to take immediate action to...

Vir Biotechnology and GSK announce global expansion to Phase 3 of COMET-ICE study

October 06, 2020: "Vir Biotechnology, Inc. and GlaxoSmithKline plc announced the global expansion to Phase 3 of the COMET-ICE (COVID-19 Monoclonal antibody...

UK inks deal with Abingdon Health for rapid COVID-19 antibody tests

October 7, 2020: "The UK authorities has introduced a deal with Abingdon Health for the provision of the corporate’s AbC-19 rapid COVID-19...

BMS Opdivo plus Yervoy misses the mark in high-risk melanoma Patients

October 02, 2020: "Bristol Myers Squibb announced results for the co-primary endpoint for CheckMate -915, a randomized Phase 3 study evaluating Opdivo (nivolumab) plus Yervoy (ipilimumab) versus Opdivo for...

COVID-19 disrupting mental health services in most countries, WHO survey

October 05, 2020: The COVID-19 pandemic has disrupted or halted critical mental health services in 93% of countries worldwide while the demand...

Novartis Beovu® showed improvement in best-corrected visual acuity in wet AMD patients with early persistent fluid

October 5, 2020: "Novartis announced that results of two new post-hoc analyses of the Phase III HAWK and HARRIER clinical trials in wet...

COVID-19 vaccine AZD1222 clinical trial resumed in Japan

 October 2020: "The Phase I/II clinical trial for the COVID-19 vaccine AZD1222 has resumed in Japan after discussion with the Japanese Pharmaceuticals...

FDA Ok Eton Pharmaceuticals ALKINDI® SPRINKLE as Replacement Therapy in Pediatric Patients

 Sept. 29, 2020: "Eton Pharmaceuticals, a specialty pharmaceutical company focused on developing and commercializing innovative treatments for rare pediatric diseases, today announced...

New contract with UK DHSC for instrument platforms and COVID-19 testing kits

29 September 2020: "Novacy, an international specialist in clinical diagnostics, announces it has signed a new supply contract with the UK Department...

FDA Issues Final Guidance for Certain Labeling Recommendations for Breast Implants

September 28, 2020: "The U.S. FDA issued the final guidance, “Breast Implants - Certain Labeling Recommendations to Improve Patient Communication,” as part...

Most Read

AZ’s Tagrisso scores priority review from FDA with EGFR-mutated lung cancer

October 20, 2020: "AstraZeneca’s Tagrisso (osimertinib) has received acceptance for its supplemental New Drug Application (sNDA) and has also been granted Priority Review in...

Forxiga recommended for approval in the EU by CHMP for heart failure

October 19, 2020: "AstraZeneca’s Forxiga (dapagliflozin) has been recommended for an indication extension of its marketing authorisation in the European Union (EU) for the...

AstraZeneca advances leadership in renal disease at ASN Kidney Week 2020 Reimagined

October 20, 2020: AstraZeneca will present 84 abstracts, including 12 oral presentations and three late-breaking abstracts, across its industry-leading renal portfolio which...

AbbVie’s VENCLEXTA® Receives FDA Approval for Acute Myeloid Leukemia

October 16, 2020: "AbbVie announced that the U.S. Food and Drug Administration (FDA) has provided full approval to VENCLEXTA® (venetoclax) in combination...